表紙:陽圧呼吸 (PAP) デバイスの世界市場 (2021-2030年):製品タイプ・適応症・エンドユーザー・疫学・服薬遵守率・中断率・地域分析
市場調査レポート
商品コード
1036775

陽圧呼吸 (PAP) デバイスの世界市場 (2021-2030年):製品タイプ・適応症・エンドユーザー・疫学・服薬遵守率・中断率・地域分析

Positive Airway Pressure Devices Market - A Global and Regional Analysis: Focus on Product Type, Indication, End User, Epidemiology, Compliance Rate, Discontinuation, and Regional Analysis - Analysis and Forecast, 2021-2030

出版日: | 発行: BIS Research Inc. | ページ情報: 英文 221 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.77円
陽圧呼吸 (PAP) デバイスの世界市場 (2021-2030年):製品タイプ・適応症・エンドユーザー・疫学・服薬遵守率・中断率・地域分析
出版日: 2021年11月15日
発行: BIS Research Inc.
ページ情報: 英文 221 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の陽圧呼吸 (PAP) デバイスの市場規模は予測期間中6.03%のCAGRで推移し、2020年の34億1,150万米ドルから、2030年には62億1,850万米ドルの規模に成長すると予測されています。

閉塞性睡眠時無呼吸症と慢性呼吸器疾患の有病率の増加が同市場の成長を推進しています。一部の国では、PAP療法のメリットに対する認識が高まっており、過去数年でこれらの国におけるPAP療法の普及率が上昇しています。

当レポートでは、世界の陽圧呼吸 (PAP) デバイスの市場を調査し、市場の定義と概要、疫学動向・償還動向、市場影響因子の分析、法規制環境、技術・特許の動向、市場規模の推移・予測、製品タイプ・適応症・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 製品の定義

第2章 調査範囲

第3章 調査手法

第4章 PAPデバイスの疫学状況・償還状況

第5章 世界のPAPデバイス市場:COVID-19の影響

第6章 産業分析

  • 産業構造
  • 主要な技術動向
  • バリューチェーン/サプライチェーン分析
  • 規制の枠組み
  • 特許分析

第7章 競合情勢

  • 市場シェア分析
  • 主な展開・戦略
  • ビジネスモデル分析
  • 価格分析

第8章 世界のPAPデバイス市場

  • 仮定・制約
  • 主な調査結果・機会の評価
  • 世界のPAPデバイス市場の成長シナリオ
  • 市場力学
    • 影響分析
    • 成長促進要因
    • 成長阻害因子
    • 成長機会

第9章 世界のPAPデバイス市場:製品タイプ別

  • 市場機会評価
  • 成長・シェアマトリックス
  • 持続的陽圧呼吸デバイス (CPAP)
  • 自動陽圧呼吸デバイス (APAP)
  • 二相式陽圧呼吸デバイス (BiPAP)

第10章 世界のPAPデバイス市場:適応症別

  • 市場機会評価
  • 成長・シェアマトリックス
  • 睡眠時無呼吸症
  • 慢性閉塞性肺疾患 (COPD)
  • その他

第11章 世界のPAPデバイス市場:エンドユーザー別

  • 市場機会評価
  • 成長・シェアマトリックス
  • 睡眠ラボ
  • ホームケア
  • その他 (病院&診療所・老人ホーム・介護施設など)

第12章 世界のPAPデバイス市場:地域別

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第13章 企業プロファイル

  • 3B Medical, Inc
  • Apex Medical Corporation
  • BMC Medical Co. Ltd.
  • Breas Medical AB
  • Compumedics Limited
  • Drive DeVilbiss Healthcare
  • Elmaslar Group
  • Fisher & Paykel Healthcare Corporation Limited
  • Hebei Topson Medical Technology Co., Ltd.
  • Kare Medical and Analytical Devices Ltd. Co.
  • Koninklijke Philips N.V.
  • Lowenstein Medical Technology GmbH+Co. KG.
  • Narang Medical Limited
  • ResMed Inc.
  • Somnetics International, Inc.
図表

List of Figures

  • Figure 1: Global Positive Airway Pressure Devices Market Dynamics Impact Analysis
  • Figure 2: Philips Recall: Primary Verbatim
  • Figure 3: Potential COVID-19 Future Scenarios of Global Positive Airway Pressure Devices Market
  • Figure 4: Global Positive Airway Pressure Devices Market Growth-Share Matrix, 2020-2030
  • Figure 5: Global Positive Airway Pressure Devices Market Segmentation
  • Figure 6: Global Positive Airway Pressure Devices Market, Research Methodology
  • Figure 7: Primary Research
  • Figure 8: Secondary Research
  • Figure 9: Data Triangulation
  • Figure 10: Global Positive Airway Pressure Devices Market Research Process
  • Figure 11: Assumptions and Limitations
  • Figure 12: Global Prevalence and Incidence (Obstructive Sleep Apnea), 2015-2026
  • Figure 13: Global Prevalence and Incidence (Chronic Obstructive Pulmonary Disorder), 2015-2026
  • Figure 14: Global Prevalence and Incidence (COVID-19), January 22, 2020-January 01, 2021
  • Figure 15: Asthma Incidence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 16: Asthma Prevalence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 17: Pneumoconiosis Incidence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 18: Pneumoconiosis Prevalence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 19: Upper Respiratory Tract Infections Incidence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 20: Upper Respiratory Tract Infections Prevalence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 21: Lower Respiratory Tract Infections Incidence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 22: Lower Respiratory Tract Infections Prevalence Y-o-Y Analysis (by Region), 1991-2026
  • Figure 23: COVID-19 Scenario Comparison Analysis on Positive Airway Pressure Devices Market
  • Figure 24: Global Positive Airway Pressure Devices Market Industry Structure
  • Figure 25: Global Positive Airway Pressure Devices Market, Key Trends
  • Figure 26: Global Positive Airway Pressure Devices Market Key Trends, Short-Term Impact Analysis, 2023-2025
  • Figure 27: Global Positive Airway Pressure Devices Market, Key Trends, Mid-Term Impact Analysis, 2025-2029
  • Figure 28: Global Positive Airway Pressure Devices Market Key Trends, Long-Term Impact Analysis, 2029-2033
  • Figure 29: Global Positive Airway Pressure Devices Market Supply Chain Analysis
  • Figure 30: Global Positive Airway Pressure Devices Market: Regulatory Landscape
  • Figure 31: EU Regulatory Pathway for Medical Device
  • Figure 32: NMPA Regulatory Pathway for Medical Device
  • Figure 33: PMDA Regulatory Pathway for Medical Device
  • Figure 34: Global Positive Airway Pressure Devices Market: Patent Publishing Trend (by Year)
  • Figure 35: Global Positive Airway Pressure Devices Market: Patent Publishing Trend (by Country/Cluster)
  • Figure 36: Global Positive Airway Pressure Therapy Market, Company Revenue Share Analysis, $Million, 2020
  • Figure 37: Share of Key Developments and Strategies in the Global Positive Airway Pressure Devices Market (by Category), January 2018-October 2021
  • Figure 38: Global Positive Airway Pressure Devices Market Key Developments (by Year), January 2018-October 2021
  • Figure 39: Global Positive Airway Pressure Devices Market New Offerings (by Company), January 2018-October 2021
  • Figure 40: Global Positive Airway Pressure Devices Market Partnerships, Alliances, and Business Expansions (by Company), January 2018-October 2021
  • Figure 41: Global Positive Airway Pressure Devices Market Regulatory and Legal Activities (by Company), January 2018-October 2021
  • Figure 42: Global Positive Airway Pressure Devices Market Mergers and Acquisitions (by Company), January 2018-October 2021
  • Figure 43: Global Positive Airway Pressure Devices Market Incremental Opportunity, $Million, 2020-2030
  • Figure 44: Global Positive Airway Pressure Devices Market, Potential Forecast Scenarios
  • Figure 45: Global Positive Airway Pressure Devices Market Size and Growth Potential (Realistic Scenario), $Million, 2019-2030
  • Figure 46: Global Positive Airway Pressure Devices Market Size and Growth Potential (Optimistic Scenario), $Million, 2019-2030
  • Figure 47: Global Positive Airway Pressure Devices Market Size and Growth Potential (Pessimistic Scenario), $Million, 2019-2030
  • Figure 48: Global Positive Airway Pressure Devices Market Dynamics Impact Analysis
  • Figure 49: Global Prevalence (Obstructive Sleep Apnea), 2015-2026
  • Figure 50: Global Positive Airway Pressure Devices Market (by Product Type)
  • Figure 51: Global Positive Airway Pressure Devices Market Incremental Opportunity (by Product Type), $Million, 2020-2030
  • Figure 52: Global Positive Airway Pressure Devices Market Growth-Share Matrix (by Product Type), 2020-2030
  • Figure 53: Global Positive Airway Pressure Devices Market (CPAP), $Million, 2019-2030
  • Figure 54: Global Positive Airway Pressure Devices Market (APAP), $Million, 2019-2030
  • Figure 55: Global Positive Airway Pressure Devices Market (BiPAP), $Million, 2019-2030
  • Figure 56: Global Positive Airway Pressure Devices Market (by Indication)
  • Figure 57: Global Positive Airway Pressure Devices Market Incremental Opportunity (by Indication), $Million, 2020-2030
  • Figure 58: Global Positive Airway Pressure Devices Market Growth-Share Matrix (by Indication), 2020-2030
  • Figure 59: Global Positive Airway Pressure Devices Market (Sleep Apnea), $Million, 2019-2030
  • Figure 60: Global Positive Airway Pressure Devices Market (COPD), $Million, 2019-2030
  • Figure 61: Global Positive Airway Pressure Devices Market (Others), $Million, 2019-2030
  • Figure 62: Global Positive Airway Pressure Devices Market (by End User)
  • Figure 63: Global Positive Airway Pressure Devices Market Incremental Opportunity (by End User), $Million, 2020-2030
  • Figure 64: Global Positive Airway Pressure Devices Market Growth-Share Matrix (by End User), 2020-2030
  • Figure 65: Global Positive Airway Pressure Devices Market (Sleep Laboratories), $Million, 2019-2030
  • Figure 66: Global Positive Airway Pressure Devices Market (Home Care), $Million, 2019-2030
  • Figure 67: Global Positive Airway Pressure Devices Market (Others), $Million, 2019-2030
  • Figure 68: Global Positive Airway Pressure Devices Market (by Region), $Million, 2019-2030
  • Figure 69: North America Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 70: North America Positive Airway Pressure Devices Market (by Product Type), $Million, 2019-2030
  • Figure 71: North America Positive Airway Pressure Devices Market (by Indication), $Million, 2019-2030
  • Figure 72: North America Positive Airway Pressure Devices Market (by End User), $Million 2019-2030
  • Figure 73: North America Positive Airway Pressure Devices Market (by Country), $Million 2019 and 2030
  • Figure 74: U.S. Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 75: Canada Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 76: Europe Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 77: Europe Positive Airway Pressure Devices Market (by Product Type), $Million, 2019-2030
  • Figure 78: Europe Positive Airway Pressure Devices Market (by Indication), $Million, 2019-2030
  • Figure 79: Europe Positive Airway Pressure Devices Market (by End User), $Million, 2019-2030
  • Figure 80: Europe Positive Airway Pressure Devices Market Share Analysis (by Country), $Million, 2019 and 2030
  • Figure 81: Germany Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 82: U.K. Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 83: France Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 84: Italy Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 85: Spain Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 86: Nordic Countries Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 87: Rest-of-Europe Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 88: Asia-Pacific Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 89: Asia-Pacific Positive Airway Pressure Devices Market (by Product Type), $Million, 2019-2030
  • Figure 90: Asia-Pacific Positive Airway Pressure Devices Market (by Indication), $Million, 2019-2030
  • Figure 91: Asia-Pacific Positive Airway Pressure Devices Market (by End User), $Million, 2019-2030
  • Figure 92: Asia-Pacific Positive Airway Pressure Devices Market Share Analysis (by Country), $Million, 2019 and 2030
  • Figure 93: Japan Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 94: China Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 95: India Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 96: Australia and New Zealand Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 97: South Korea Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 98: Rest-of-Asia-Pacific Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 99: Latin America Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 100: Latin America Positive Airway Pressure Devices Market (by Product Type), $Million, 2019-2030
  • Figure 101: Latin America Positive Airway Pressure Devices Market (by Indication), $Million, 2019-2030
  • Figure 102: Latin America Positive Airway Pressure Devices Market (by End User), $Million, 2019-2030
  • Figure 103: Latin America Positive Airway Pressure Devices Market Share Analysis (by Country), $Million, 2019 and 2030
  • Figure 104: Brazil Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 105: Mexico Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 106: Argentina Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 107: Colombia Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 108: Rest-of-Latin America Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 109: Middle East and Africa Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 110: Middle East and Africa Positive Airway Pressure Devices Market (by Product Type), $Million, 2019-2030
  • Figure 111: Middle East and Africa Positive Airway Pressure Devices Market (by Indication), $Million, 2019-2030
  • Figure 112: Middle East and Africa Positive Airway Pressure Devices Market (by End User), $Million, 2019-2030
  • Figure 113: Middle East and Africa Positive Airway Pressure Devices Market Share Analysis (by Country), $Million, 2019 and 2030
  • Figure 114: K.S.A. Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 115: U.A.E. Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 116: South Africa Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 117: Rest-of-Middle East and Africa Positive Airway Pressure Devices Market, $Million, 2019-2030
  • Figure 118: 3B Medical, Inc: Overall Product Portfolio
  • Figure 119: 3B Medical, Inc.: SWOT Analysis
  • Figure 120: Apex Medical Corporation: Overall Product Portfolio
  • Figure 121: Apex Medical Corporation: SWOT Analysis
  • Figure 122: BMC Medical Co. Ltd.: Overall Product Portfolio
  • Figure 123: BMC Medical Co. Ltd.: SWOT Analysis
  • Figure 124: Breas Medical AB: Overall Product Portfolio
  • Figure 125: Breas Medical AB: SWOT Analysis
  • Figure 126: Compumedics Limited: Overall Product Portfolio
  • Figure 127: Compumedics Limited: Overall Financials, $Million, 2019-2021
  • Figure 128: Compumedics Limited: Revenue (by Region), $Million, 2019-2021
  • Figure 129: Compumedics Limited: Research and Development Expenditure, $Million, 2019-2021
  • Figure 130: Compumedics Limited: SWOT Analysis
  • Figure 131: Drive DeVilbiss Healthcare: Overall Product Portfolio
  • Figure 132: Drive DeVilbiss Healthcare: SWOT Analysis
  • Figure 133: Elmaslar Group: Overall Product Portfolio
  • Figure 134: Elmaslar Group: SWOT Analysis
  • Figure 135: Fisher & Paykel Healthcare Corporation Limited: Overall Product Portfolio
  • Figure 136: Fisher & Paykel Healthcare Corporation Limited: Overall Financials, $Million, 2019-2021
  • Figure 137: Fisher & Paykel Healthcare Corporation Limited.: Revenue (by Segment), $Million, 2019-2021
  • Figure 138: Fisher & Paykel Healthcare Corporation Limited: Revenue (by Region), $Million, 2019-2021
  • Figure 139: Fisher & Paykel Healthcare Corporation Limited: Research and Development Expenditure, $Million, 2019-2021
  • Figure 140: Fisher & Paykel Healthcare Corporation Limited: SWOT Analysis
  • Figure 141: Hebei Topson Medical Technology Co., Ltd.: Overall Product Portfolio
  • Figure 142: Hebei Topson Medical Technology Co., Ltd: SWOT Analysis
  • Figure 143: Kare Medical and Analytical Devices Ltd. Co.: Overall Product Portfolio
  • Figure 144: Kare Medical and Analytical Devices Ltd. Co.: SWOT Analysis
  • Figure 145: Koninklijke Philips N.V.: Overall Product Portfolio
  • Figure 146: Koninklijke Philips N.V.: Overall Financials, $Million, 2018-2020
  • Figure 147: Koninklijke Philips N.V.: Revenue (by Business Segment), $Million, 2018-2020
  • Figure 148: Koninklijke Philips N.V.: Revenue (by Region), $Million, 2018-2020
  • Figure 149: Koninklijke Philips N.V.: SWOT Analysis
  • Figure 150: Lowenstein Medical Technology GmbH + Co. KG.: Overall Product Portfolio
  • Figure 151: Lowenstein Medical Technology GmbH + Co. KG.: SWOT Analysis
  • Figure 152: Narang Medical Limited: Overall Product Portfolio
  • Figure 153: Narang Medical Limited: SWOT Analysis
  • Figure 154: ResMed Inc.: Overall Product Portfolio
  • Figure 155: ResMed Inc.: Overall Financials, $Million, 2019-2021
  • Figure 156: ResMed Inc.: Net Revenue (by Segment), $Million, 2019-2021
  • Figure 157: ResMed Inc.: Revenue (by Region), $Million, 2019-2021
  • Figure 158: ResMed Inc.: Research and Development Expenditure, $Million, 2019-2021
  • Figure 159: ResMed Inc.: SWOT Analysis
  • Figure 160: Somnetics International, Inc.: Overall Product Portfolio
  • Figure 161: Somnetics International, Inc.: SWOT Analysis

List of Tables

  • Table 1: Global Positive Airway Pressure Devices Market Challenges
  • Table 2: Global Positive Airway Pressure Devices Market Key Developments Analysis, January 2018-October 2021
  • Table 3: Global Positive Airway Pressure Devices Market COVID-19 Recovery Scenario Impact
  • Table 4: PAP Devices Reimbursement Schemes in Australia
  • Table 5: Key Barriers and Possible Solutions in Entering into the Global Positive Airway Pressure Devices Market
  • Table 6: European Commission Medical Device Directives
  • Table 7: Federal Agencies of EU Member States
  • Table 8: Regulatory Bodies in Asia-Pacific
  • Table 9: Awaited Technological Developments in the Global Positive Airway Pressure Devices Market
  • Table 10: Global Positive Airway Pressure Devices Market Business Models
  • Table 11: Global Positive Airway Pressure Devices Market Pricing Analysis (by Product Type), $
  • Table 12: Opportunity Analysis (by Region), 2020 and 2021-2030
  • Table 13: North America PAP Therapy Fees
  • Table 14: U.S. PAP Therapy Fees
  • Table 15: Europe PAP Therapy Fees
  • Table 16: Germany PAP Therapy Fees
  • Table 17: U.K. PAP Therapy Fees
  • Table 18: France PAP Therapy Fees
  • Table 19: Italy PAP Therapy Fees
  • Table 20: Spain PAP Therapy Fees
  • Table 21: Asia-Pacific PAP Therapy Fees
  • Table 22: Latin America PAP Therapy Fees
  • Table 23: Middle East and Africa PAP Therapy Fees
目次
Product Code: BHM1116SA

“Global Positive Airway Pressure Devices Market to Reach $6,218.5 Million by 2030.”

Market Report Coverage - Positive Airway Pressure Devices

Market Segmentation

  • Product Type - Continuous Positive Airway Pressure Device (CPAP), Automatic Positive Airway Pressure Device (APAP), Bi-Level Positive Airway Pressure Device (BiPAP)
  • Indication - Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Others
  • End User - Sleep Laboratories, Home Care, Others (Hospitals and Clinics, Elderly Care Homes, Nursing Homes, etc.)

Regional Segmentation

  • North America - U.S. and Canada
  • Europe - Germany, U.K., France, Italy, Spain, Nordic Countries, and Rest-of-Europe
  • Asia-Pacific - Japan, China, India, Australia and New Zealand, South Korea, and the Rest-of-Asia-Pacific
  • Latin America - Brazil, Mexico, Argentina, Colombia, and the Rest-of-Latin America
  • Middle East and Africa - K.S.A., U.A.E., South Africa, and the Rest-of-Middle East and Africa
a

Market Growth Drivers

  • Rising Number of Startups Driving Innovation
  • Increasing Prevalence of Obstructive Sleep Apnea
  • Growing Prevalence of Respiratory Diseases among the Geriatric Population
  • Growing Prevalence of Chronic Respiratory Diseases across the Globe

Market Challenges

  • High Upfront Cost of the Devices
  • Side-Effects Associated with Long-Term Usage

Market Opportunities

  • Development of Smart PAP Devices
  • Deployment of 3D Scanning to Offer Customized PAP Masks
  • Development of Accessory-Free PAP Devices

Key Companies Profiled

3B Medical, Inc, Apex Medical Corporation, BMC Medical Co. Ltd., Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Elmaslar Group, Fisher & Paykel Healthcare Corporation Limited, Hebei Topson Medical Technology Co., Ltd., Kare Medical and Analytical Devices Ltd. Co., Koninklijke Philips N.V., Lowenstein Medical Technology GmbH + Co. KG., Narang Medical Limited, ResMed Inc., Somnetics International, Inc.

How This Report Can Add Value

Assuming that the reader is a manufacturer of positive airway pressure devices, they will be able to do the following:

  • Understand their position as compared to some of the key players in the market
  • Get information on parameters such as device adoption rate, therapy compliance rate, and discontinuation rate
  • Assess the disease epidemiology in each region
  • Familiarize themselves with the necessary information related to changing market dynamics
  • Stay updated with the latest trends in the market with respect to connected devices
  • Understand the impact of COVID-19 on the market
  • Identify some of the key players in the market and understand their value contribution

Key Questions Answered in the Global Positive Airway Pressure Devices Market Report:

  • How has COVID-19 impacted the adoption of PAP devices in the market?
  • What are the key regulations which influence the adoption of PAP devices in the market?
  • What are some of the key companies in the global and regional PAP market?
  • What are some of the key factors influencing the growth in adopting PAP devices across the globe?
  • What are some of the growth opportunities which market players can capitalize on?
  • What is the PAP device adoption rate for patients diagnosed with sleep apnea?
  • What are the compliance and discontinuation rates for PAP therapy across regions?
  • What are the fastest-growing countries in terms of PAP devices adoption?
  • Which are the key diseases driving the adoption of PAP devices across the world?
  • What are the key strategies being adopted by market players in the global positive airway pressure devices market?
  • Who are the most common end-users of PAP devices, and how are the end-use segment expected to grow in the future?

Positive Airway Pressure Devices Market Industry Overview

A positive airway pressure delivery system is a prescription non-invasive ventilatory device that delivers expiratory positive airway pressure for patients suffering from obstructive sleep apnea. The system also provides positive airway pressure during incipient apnea. The system may include a dedicated flow generator and a patient interface.

Sleep apnea is a sleep-related breathing disorder that involves a decrease or complete halt in airflow despite an ongoing effort to breathe. It occurs when the muscles relax during sleep, causing the soft tissue at the back of the throat to collapse and block the upper airway. Obstructive sleep apnea is also one of the independent risk factors for stroke, cardiovascular diseases, and systemic hypertension, among other clinical consequences. Globally, sleep apnea impacts more than 936 million individuals worldwide. The American Academy of Sleep Medicine (AASM) recommends that continuous positive airway pressure (CPAP) devices be considered first-line treatment for moderate and severe OSA.

Despite the recommendations, CPAP devices and PAP devices in general frequently encounter challenges in terms of adherence. There are a number of factors that contribute to the low adherence rates for PAP devices. These factors primarily include claustrophobia, discomfort, and high cost. Several studies have been conducted to identify the reason behind low adherence rates despite several changes in the device and mask dynamics.

The global positive airway pressure devices market report highlights that the market was valued at $3,411.5 million in 2020 and is expected to reach $6,218.5 million by the end of 2030. The market is expected to grow at a CAGR of 6.03% during the forecast period from 2021 to 2030.

Global Positive Airway Pressure Devices Market Drivers

Currently, the market is mainly being driven by the growing prevalence of obstructive sleep apnea and chronic respiratory diseases. Some countries have registered increasing awareness of the benefits of positive airway pressure (PAP) therapy, and as a result, there has been a hike in the prevalence of PAP therapy in those countries in the past few years.

There has been a steady growth in the number of health-tech startups in the industry. The market entry of new players has been further accelerated by the COVID-19 pandemic. MedTech startups have been responding to the growing demand for ventilators by offering non-invasive unconventional systems and indigenous ventilators. Apart from that, globally, the prevalence of obstructive sleep apnea is expected to exceed 986 million cases by the end of 2026. According to data obtained from the Global Data Health Exchange and BIS Research analysis, the incidence of the condition in North America was as high as 1 in 11 individuals in 2020. The life expectancy in most countries has surged tremendously. The improvement in life expectancy is due to significant advancements in diagnostic technology and medical science. Furthermore, growing awareness regarding health, nutrition, and hygiene has also resulted in increased life expectancy.

The prevalence of diseases among the growing geriatric population has grown at a significant pace during 2015-2019 as compared to those aged 54 and below.

Global Positive Airway Pressure Devices Market Challenges

The primary challenge is the lack of awareness of the benefits of positive airway pressure therapy among individuals. Sleep apnea itself faces a significant challenge in getting diagnosed with many individuals unaware that they suffer from the condition. A key restraining factor to the growth in the adoption of PAP devices is their high cost. Additionally, the lack of reimbursement policies by the government and commercial payors also hampers the adoption of PAP devices in emerging economies. These devices are also uncomfortable for many users, which results in the discontinuation of therapy. The global positive airway pressure devices market is also expected to be restrained due to non-adherence.

Global Positive Airway Pressure Devices Market Opportunities

Owing to the rising focus on remote patient monitoring, mobile health applications, and integration of telemedicine in treatment and diagnostic aspects of healthcare, the development of smart PAP devices offers a novel opportunity to both established and emerging players.

Established PAP device manufacturers can develop devices integrated with a mobile application that would enable patients to monitor their breathing quality, sleep quality, and therapy adherence. Moreover, the mobile application could further facilitate data sharing with a physician for patient monitoring. For instance, Koninklijke Philips N.V. developed DreamMapper, a mobile application compatible with its CPAP devices. The mobile application offers various features such as therapy hours, educational information, progress monitoring, and data sharing with physicians.

Impact of COVID-19 on the Positive Airway Pressure Devices Industry

The impact of COVID-19 varies depending on the region, country, the extent of lockdowns, and the perception of the local population.

The market witnessed a temporary boost in demand when CPAP devices were approved for emergency use by regulatory bodies to bridge the gap between demand for and supply of ventilators.

Key areas of the supply chain were impacted during the initial days of the pandemic, which comprised coinciding lockdowns in several countries leading to a restriction in global logistics. The resulting strain led to reduced stock in warehouses and a hike in logistics costs locally.

Market Segmentation

Global Positive Airway Pressure Devices Market (by Product Type)

CPAPs are considered the gold standard for the treatment of sleep apnea.

The growth in the adoption of CPAP devices across various segments can be attributed to the rise in the prevalence of breathing difficulties, which has led to more doctors prescribing such devices. The history of CPAP therapy can be traced back to the 1950s with the commencement of early sleep studies. The major challenge associated with recording data in that era was the lack of any digital means to implement CPAP. The use of APAP is mostly restricted to those with moderate-to-severe obstructive sleep apnea (OSA). The main barriers to the adoption of APAP devices in the market include low diagnosis rates for those suffering from OSA. APAP devices are also priced higher than CPAP devices which are considered the gold standard therapy for OSA.

BiPAP devices have two pressure settings - inhalation PAP and exhalation PAP. Depending on the settings of the device, the switch between inhalation and exhalation can be timed or automatically based on the individual's breathing patterns. In some cases, BiPAP devices are considered a better option for some individuals. BiPAPs are priced much higher than CPAP and APAP devices and face low adoption rates.

Global Positive Airway Pressure Devices Market (by Indication)

Sleep apnea is the dominant indication for which positive airway pressure therapy is recommended. Sleep apnea remains undiagnosed among a significant chunk of the individuals who have it. There are several more filters which lead to low adoption rates of positive airway pressure devices.

Global Positive Airway Pressure Devices Market (by End User)

Traditionally, sleep studies were usually conducted at sleep laboratories to monitor physiological data such as heart rate, breathing, and oxygen levels to diagnose sleeping disorders. However, owing to apprehensions regarding COVID-19 transmission, the pandemic witnessed a decline in the instances of studies conducted at these centers. The demand created by sleep laboratories is expected to return to normal post the pandemic as patients suffering from severe OSA requiring in-clinic monitoring continue to visit sleep laboratories.

Global Positive Airway Pressure Devices Market (by Region)

The different regions covered under the global positive airway pressure devices market include North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

North America and Europe are two of the largest markets for positive airway pressure devices, while developing countries are expected to register strong growth in the adoption of positive airway pressure devices in the near future.

Key Market Players and Competition Synopsis

Some of the key players operating in the market include: 3B Medical, Inc, Apex Medical Corporation, BMC Medical Co. Ltd., Breas Medical AB, Compumedics Limited, Drive DeVilbiss Healthcare, Elmaslar Group, Fisher & Paykel Healthcare Corporation Limited, Hebei Topson Medical Technology Co., Ltd., Kare Medical and Analytical Devices Ltd. Co., Koninklijke Philips N.V., Lowenstein Medical Technology GmbH + Co. KG., Narang Medical Limited, ResMed Inc., and Somnetics International, Inc.

Table of Contents

1. Product Definition

2. Scope of Research

  • 2.1. Scope of Study
  • 2.2. Inclusion and Exclusion Criteria
  • 2.3. Key Questions Answered in the Report

3. Research Methodology

  • 3.1. Data Collection and Analysis
  • 3.2. Data Sources
    • 3.2.1. Primary Data Sources
    • 3.2.2. Secondary Data Sources
  • 3.3. Data Triangulation
  • 3.4. Market Estimation
  • 3.5. Forecast Period Selection Criteria
  • 3.6. Assumptions and Limitations

4. Epidemiological and Reimbursement Landscape for PAP Devices

  • 4.1. Epidemiological Landscape
    • 4.1.1. Obstructive Sleep Apnea (OSA)
      • 4.1.1.1. Regional Analysis for PAP Devices
    • 4.1.2. Chronic Obstructive Pulmonary Disorder (COPD)
      • 4.1.2.1. Regional Analysis for PAP Devices
    • 4.1.3. COVID-19
      • 4.1.3.1. Regional Analysis for PAP Devices
    • 4.1.4. Other Respiratory Disorders
  • 4.2. Reimbursement Landscape
    • 4.2.1. North America
    • 4.2.2. Europe
    • 4.2.3. Asia-Pacific

5. Impact of COVID-19 on Global Positive Airway Pressure (PAP) Devices Market

  • 5.1. Impact on Regulatory Authorities
  • 5.2. Impact on Adoption of Positive Airway Pressure Devices
  • 5.3. Impact on Market Size of Positive Airway Pressure Devices
    • 5.3.1. Scenario Comparison Analysis
    • 5.3.2. Regional Impact
  • 5.4. Future Impact of COVID-19
    • 5.4.1. Short-Term Impact (2-4 Years)
    • 5.4.2. Mid-Term Impact (5-10 Years)
    • 5.4.3. Long-Term Impact (8-12 Years)
  • 5.5. Entry Barriers and Opportunities for New Companies

6. Industry Analysis

  • 6.1. Industry Structure
  • 6.2. Key Technological Trends
    • 6.2.1. Short-Term Potential (2-4 Years)
    • 6.2.2. Mid-Term Potential (4-8 Years)
    • 6.2.3. Long Term Potential (8-12 Years)
  • 6.3. Value Chain/Supply Chain Analysis
  • 6.4. Regulatory Framework
    • 6.4.1. Regulations in North America
      • 6.4.1.1. Food and Drug Administration (FDA)
      • 6.4.1.2. Health Canada
    • 6.4.2. Regulations in Europe
    • 6.4.3. Regulations in Asia-Pacific
      • 6.4.3.1. National Medical Products Administration (NMPA)
      • 6.4.3.2. Pharmaceutical and Medical Device Agency (PMDA)
  • 6.5. Patent Analysis
    • 6.5.1. Awaited Technological Developments
    • 6.5.2. Patent Trend (by Year)
    • 6.5.3. Patent Trend (by Country/Cluster)

7. Competitive Landscape

  • 7.1. Market Share Analysis
  • 7.2. Key Developments and Strategies
    • 7.2.1. New Offerings
    • 7.2.2. Partnerships, Alliances, and Business Expansions
    • 7.2.3. Regulatory and Legal Activities
    • 7.2.4. Mergers and Acquisitions
  • 7.3. Business Model Analysis
  • 7.4. Pricing Analysis

8. Global Positive Airway Pressure (PAP) Devices Market

  • 8.1. Assumptions and Limitations
  • 8.2. Key Findings and Opportunity Assessment
  • 8.3. Global Positive Airway Pressure Devices Market Growth Scenario
    • 8.3.1. Realistic Growth
    • 8.3.2. Optimistic Growth
    • 8.3.3. Pessimistic/Conservative Growth
  • 8.4. Market Dynamics
    • 8.4.1. Impact Analysis
    • 8.4.2. Growth Promoting Factors
      • 8.4.2.1. Rising Number of Startups Driving Innovation
      • 8.4.2.2. Increasing Prevalence of Obstructive Sleep Apnea
      • 8.4.2.3. Growing Prevalence of Respiratory Diseases among the Geriatric Population
      • 8.4.2.4. Growing Prevalence of Chronic Respiratory Diseases across the Globe
    • 8.4.3. Growth Inhibiting Factors
      • 8.4.3.1. High Upfront Cost of the Devices
      • 8.4.3.2. Side-Effects Associated with Long-Term Usage
    • 8.4.4. Growth Opportunities
      • 8.4.4.1. Development of Smart PAP Devices
      • 8.4.4.2. Deployment of 3D Scanning to Offer Customized PAP Masks
      • 8.4.4.3. Development of Accessory-Free PAP Devices
        • 8.4.4.3.1. Regional Analysis of Growth Opportunities

9. Global Positive Airway Pressure Devices Market (by Product Type)

  • 9.1. Opportunity Assessment
  • 9.2. Growth-Share Matrix
  • 9.3. Continuous Positive Airway Pressure Device (CPAP)
  • 9.4. Automatic Positive Airway Pressure Device (APAP)
  • 9.5. Bi-Level Positive Airway Pressure Device (BiPAP)

10. Global Positive Airway Pressure Devices Market (by Indication)

  • 10.1. Opportunity Assessment
  • 10.2. Growth-Share Matrix
  • 10.3. Sleep Apnea
  • 10.4. Chronic Obstructive Pulmonary Disease (COPD)
  • 10.5. Others

11. Global Positive Airway Pressure Devices Market (by End User)

  • 11.1. Opportunity Assessment
  • 11.2. Growth-Share Matrix
  • 11.3. Sleep Laboratories
  • 11.4. Home Care
  • 11.5. Others (Hospitals and Clinics, Elderly Care Homes, Nursing Homes, etc.)

12. Global Positive Airway Pressure Devices Market (by Region)

  • 12.1. Overview
  • 12.2. North America Positive Airway Pressure Devices Market
    • 12.2.1. Key Findings
      • 12.2.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
      • 12.2.1.2. PAP Therapy Compliance Rate
      • 12.2.1.3. PAP Therapy Discontinuation Rate
      • 12.2.1.4. Fees Associated with PAP Therapy
    • 12.2.2. Market Size and Forecast
    • 12.2.3. North America Positive Airway Pressure Devices Market (by Product Type)
    • 12.2.4. North America Positive Airway Pressure Devices Market (by Indication)
    • 12.2.5. North America Positive Airway Pressure Devices Market (by End User)
    • 12.2.6. North America Positive Airway Pressure Devices Market Share Analysis (by Country), 2019 and 2030
      • 12.2.6.1. U.S.
        • 12.2.6.1.1. Key Findings
          • 12.2.6.1.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
          • 12.2.6.1.1.2. PAP Therapy Compliance Rate
          • 12.2.6.1.1.3. PAP Therapy Discontinuation Rate
          • 12.2.6.1.1.4. Fees Associated with PAP Therapy
        • 12.2.6.1.2. Market Dynamics
        • 12.2.6.1.3. Market Size and Forecast
      • 12.2.6.2. Canada
        • 12.2.6.2.1. Market Dynamics
        • 12.2.6.2.2. Market Size and Forecast
  • 12.3. Europe Positive Airway Pressure Devices Market
    • 12.3.1. Key Findings
      • 12.3.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
      • 12.3.1.2. PAP Therapy Compliance Rate
      • 12.3.1.3. PAP Therapy Discontinuation Rate
      • 12.3.1.4. Fees Associated with PAP Therapy
    • 12.3.2. Market Size and Forecast
    • 12.3.3. Europe Positive Airway Pressure Devices Market (by Product Type)
    • 12.3.4. Europe Positive Airway Pressure Devices Market (by Indication), $Million, 2019-2030
    • 12.3.5. Europe Positive Airway Pressure Devices Market (by End User)
    • 12.3.6. Europe Positive Airway Pressure Devices Market (by Country)
      • 12.3.6.1. Germany
        • 12.3.6.1.1. Key Findings
          • 12.3.6.1.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
          • 12.3.6.1.1.2. PAP Therapy Compliance Rate
          • 12.3.6.1.1.3. PAP Therapy Discontinuation Rate
          • 12.3.6.1.1.4. Fees Associated with PAP Therapy
        • 12.3.6.1.2. Market Dynamics
        • 12.3.6.1.3. Market Size and Forecast
      • 12.3.6.2. U.K.
        • 12.3.6.2.1. Key Findings
          • 12.3.6.2.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
          • 12.3.6.2.1.2. PAP Therapy Compliance Rate
          • 12.3.6.2.1.3. PAP Therapy Discontinuation Rate
          • 12.3.6.2.1.4. Fees Associated with PAP Therapy
        • 12.3.6.2.2. Market Dynamics
        • 12.3.6.2.3. Market Size and Forecast
      • 12.3.6.3. France
        • 12.3.6.3.1. Key Findings
          • 12.3.6.3.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
          • 12.3.6.3.1.2. PAP Therapy Compliance Rate
          • 12.3.6.3.1.3. PAP Therapy Discontinuation Rate
          • 12.3.6.3.1.4. Fees Associated with PAP Therapy
        • 12.3.6.3.2. Market Dynamics
        • 12.3.6.3.3. Market Size and Forecast
      • 12.3.6.4. Italy
        • 12.3.6.4.1. Key Findings
          • 12.3.6.4.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
          • 12.3.6.4.1.2. PAP Therapy Compliance Rate
          • 12.3.6.4.1.3. PAP Therapy Discontinuation Rate
          • 12.3.6.4.1.4. Fees Associated with PAP Therapy
        • 12.3.6.4.2. Market Dynamics
        • 12.3.6.4.3. Market Size and Forecast
      • 12.3.6.5. Spain
        • 12.3.6.5.1. Key Findings
          • 12.3.6.5.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
          • 12.3.6.5.1.2. PAP Therapy Compliance Rate
          • 12.3.6.5.1.3. PAP Therapy Discontinuation Rate
          • 12.3.6.5.1.4. Fees Associated with PAP Therapy
        • 12.3.6.5.2. Market Dynamics
        • 12.3.6.5.3. Market Size and Forecast
      • 12.3.6.6. Nordic Countries
        • 12.3.6.6.1. Market Dynamics
        • 12.3.6.6.2. Market Size and Forecast
      • 12.3.6.7. Rest-of-Europe
        • 12.3.6.7.1. Market Dynamics
        • 12.3.6.7.2. Market Size and Forecast
  • 12.4. Asia-Pacific Positive Airway Pressure Devices Market
    • 12.4.1. Key Findings
      • 12.4.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
      • 12.4.1.2. PAP Therapy Compliance Rate
      • 12.4.1.3. PAP Therapy Discontinuation Rate
      • 12.4.1.4. Fees Associated with PAP Therapy
    • 12.4.2. Market Size and Forecast
    • 12.4.3. Asia-Pacific Positive Airway Pressure Devices Market (by Product Type)
    • 12.4.4. Asia-Pacific Positive Airway Pressure Devices Market (by Indication)
    • 12.4.5. Asia-Pacific Positive Airway Pressure Devices Market (by End User)
    • 12.4.6. Asia-Pacific Positive Airway Pressure Devices Market (by Country)
      • 12.4.6.1. Japan
        • 12.4.6.1.1. Market Dynamics
        • 12.4.6.1.2. Market Size and Forecast
      • 12.4.6.2. China
        • 12.4.6.2.1. Market Dynamics
        • 12.4.6.2.2. Market Size and Forecast
      • 12.4.6.3. India
        • 12.4.6.3.1. Market Dynamics
        • 12.4.6.3.2. Market Size and Forecast
      • 12.4.6.4. Australia and New Zealand
        • 12.4.6.4.1. Market Dynamics
        • 12.4.6.4.2. Market Size and Forecast
      • 12.4.6.5. South Korea
        • 12.4.6.5.1. Market Dynamics
        • 12.4.6.5.2. Market Size and Forecast
      • 12.4.6.6. Rest-of-Asia-Pacific
        • 12.4.6.6.1. Market Dynamics
        • 12.4.6.6.2. Market Size and Forecast
  • 12.5. Latin America Positive Airway Pressure Devices Market
    • 12.5.1. Key Findings
      • 12.5.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
      • 12.5.1.2. PAP Therapy Compliance Rate
      • 12.5.1.3. PAP Therapy Discontinuation Rate
      • 12.5.1.4. Fees Associated with PAP Therapy
    • 12.5.2. Market Size and Forecast
    • 12.5.3. Latin America Positive Airway Pressure Devices Market (by Product Type)
    • 12.5.4. Latin America Positive Airway Pressure Devices Market (by Indication)
    • 12.5.5. Latin America Positive Airway Pressure Devices Market (by End User)
    • 12.5.6. Latin America Positive Airway Pressure Devices Market Share Analysis (by Country)
      • 12.5.6.1. Brazil
        • 12.5.6.1.1. Market Dynamics
        • 12.5.6.1.2. Market Size and Forecast
      • 12.5.6.2. Mexico
        • 12.5.6.2.1. Market Dynamics
        • 12.5.6.2.2. Market Size and Forecast
      • 12.5.6.3. Argentina
        • 12.5.6.3.1. Market Dynamics
        • 12.5.6.3.2. Market Size and Forecast
      • 12.5.6.4. Colombia
        • 12.5.6.4.1. Market Dynamics
        • 12.5.6.4.2. Market Size and Forecast
      • 12.5.6.5. Rest-of-Latin America
        • 12.5.6.5.1. Market Dynamics
        • 12.5.6.5.2. Market Size and Forecast
  • 12.6. Middle East and Africa Positive Airway Pressure Devices Market
    • 12.6.1. Key Findings
      • 12.6.1.1. Diagnosed Sleep Apnea Patients PAP Device Adoption Rate
      • 12.6.1.2. PAP Therapy Compliance Rate
      • 12.6.1.3. PAP Therapy Discontinuation Rate
      • 12.6.1.4. Fees Associated with PAP Therapy
    • 12.6.2. Market Size and Forecast
    • 12.6.3. Middle East and Africa Positive Airway Pressure Devices Market (by Product Type)
    • 12.6.4. Middle East and Africa Positive Airway Pressure Devices Market (by Indication)
    • 12.6.5. Middle East and Africa Positive Airway Pressure Devices Market (by End User)
    • 12.6.6. Middle East and Africa Positive Airway Pressure Devices Market Share Analysis (by Country)
      • 12.6.6.1. K.S.A.
        • 12.6.6.1.1. Market Dynamics
        • 12.6.6.1.2. Market Size and Forecast
      • 12.6.6.2. U.A.E.
        • 12.6.6.2.1. Market Dynamics
        • 12.6.6.2.2. Market Size and Forecast
      • 12.6.6.3. South Africa
        • 12.6.6.3.1. Market Dynamics
        • 12.6.6.3.2. Market Size and Forecast
      • 12.6.6.4. Rest-of-Middle East and Africa
        • 12.6.6.4.1. Market Dynamics
        • 12.6.6.4.2. Market Size and Forecast

13. Company Profiles

  • 13.1. 3B Medical, Inc
    • 13.1.1. Company Overview
    • 13.1.2. Role of 3B Medical, Inc in the Global Positive Airway Pressure Devices Market
    • 13.1.3. Product Portfolio
    • 13.1.4. Recent Developments
    • 13.1.5. SWOT Analysis
  • 13.2. Apex Medical Corporation
    • 13.2.1. Company Overview
    • 13.2.2. Role of Apex Medical Corporation in the Global Positive Airway Pressure Devices Market
    • 13.2.3. Product Portfolio
    • 13.2.4. Recent Developments
    • 13.2.5. SWOT Analysis
  • 13.3. BMC Medical Co. Ltd.
    • 13.3.1. Company Overview
    • 13.3.2. Role of BMC Medical Co. Ltd. in the Global Positive Airway Pressure Devices Market
    • 13.3.3. Product Portfolio
    • 13.3.4. Recent Developments
    • 13.3.5. SWOT Analysis
  • 13.4. Breas Medical AB
    • 13.4.1. Company Overview
    • 13.4.2. Role of Breas Medical AB in the Global Positive Airway Pressure Devices Market
    • 13.4.3. Product Portfolio
    • 13.4.4. Recent Developments
    • 13.4.5. SWOT Analysis
  • 13.5. Compumedics Limited
    • 13.5.1. Company Overview
    • 13.5.2. Role of Compumedics Limited in the Global Positive Airway Pressure Devices Market
    • 13.5.3. Product Portfolio
    • 13.5.4. Financials
    • 13.5.5. Research and Development Insights
    • 13.5.6. SWOT Analysis
  • 13.6. Drive DeVilbiss Healthcare
    • 13.6.1. Company Overview
    • 13.6.2. Role of Drive DeVilbiss Healthcare in the Global Positive Airway Pressure Devices Market
    • 13.6.3. Product Portfolio
    • 13.6.4. Recent Developments
    • 13.6.5. SWOT Analysis
  • 13.7. Elmaslar Group
    • 13.7.1. Company Overview
    • 13.7.2. Role of Elmaslar Group in the Global Positive Airway Pressure Devices Market
    • 13.7.3. Product Portfolio
    • 13.7.4. SWOT Analysis
  • 13.8. Fisher & Paykel Healthcare Corporation Limited
    • 13.8.1. Company Overview
    • 13.8.2. Role of Fisher & Paykel Healthcare Corporation Limited in the Global Positive Airway Pressure Devices Market
    • 13.8.3. Product Portfolio
    • 13.8.4. Financials
    • 13.8.5. Research and Development Insights
    • 13.8.6. SWOT Analysis
  • 13.9. Hebei Topson Medical Technology Co., Ltd.
    • 13.9.1. Company Overview
    • 13.9.2. Role of Hebei Topson Medical Technology Co., Ltd. in the Global Positive Airway Pressure Devices Market
    • 13.9.3. Product Portfolio
    • 13.9.4. SWOT Analysis
  • 13.1. Kare Medical and Analytical Devices Ltd. Co.
    • 13.10.1. Company Overview
    • 13.10.2. Role of Kare Medical and Analytical Devices Ltd. Co. in the Global Positive Airway Pressure Devices Market
    • 13.10.3. Product Portfolio
    • 13.10.4. SWOT Analysis
  • 13.11. Koninklijke Philips N.V.
    • 13.11.1. Company Overview
    • 13.11.2. Role of Koninklijke Philips N.V. in the Global Positive Airway Pressure Devices Market
    • 13.11.3. Product Portfolio
    • 13.11.4. Financials
    • 13.11.5. Recent Developments
    • 13.11.6. SWOT Analysis
  • 13.12. Lowenstein Medical Technology GmbH + Co. KG.
    • 13.12.1. Company Overview
    • 13.12.2. Role of Lowenstein Medical Technology GmbH + Co. KG. in the Global Positive Airway Pressure Devices Market
    • 13.12.3. Product Portfolio
    • 13.12.4. SWOT Analysis
  • 13.13. Narang Medical Limited
    • 13.13.1. Company Overview
    • 13.13.2. Role of Narang Medical Limited in the Global Positive Airway Pressure Devices Market
    • 13.13.3. Product Portfolio
    • 13.13.4. SWOT Analysis
  • 13.14. ResMed Inc.
    • 13.14.1. Company Overview
    • 13.14.2. Role of ResMed Inc. in the Global Positive Airway Pressure Devices Market
    • 13.14.3. Product Portfolio
    • 13.14.4. Recent Developments
    • 13.14.5. Financials
    • 13.14.6. Research and Development Insights
    • 13.14.7. SWOT Analysis
  • 13.15. Somnetics International, Inc.
    • 13.15.1. Company Overview
    • 13.15.2. Role of Somnetics International, Inc. in the Global Positive Airway Pressure Devices Market
    • 13.15.3. Product Portfolio
    • 13.15.4. Recent Developments
    • 13.15.5. SWOT Analysis